Dear colleagues,

The NMN symposium aims to provide a highly interactive platform for scientific and educational exchange on the fascinating and clinically highly relevant aspects in research and application of nuclear medicine with a focus on malignancies of the central nervous system (CNS). Primary and secondary CNS tumors represent a particularly challenging and heterogenous disease entity, which is also characterized by a multitude of molecular alterations. Nuclear medicine is of particular relevance and carries an exceptionally high potential for improvements of diagnosis, molecular classification, planning of therapeutic interventions (neurosurgery, radiotherapy, targeted therapy, immunotherapy), assessment of therapy response and drug development (including assessment of blood-brain barrier penetration) in the field of Neuro-Oncology.

On behalf of the Scientific Committee composed of high-ranking experts from various disciplines, we very much look forward to welcoming you on May 07/08th 2026 in Vienna for the next edition of the NMN Symposium. We look forward to exciting scientific exchange, the strengthening of collaborations and friendships, and, if our busy symposium schedule allows, also the enjoyment of the wide range of cultural and culinary pleasures the beautiful city of Vienna has to offer!